ClinicalTrials.Veeva

Menu

The Effects of Pumpkin Seed Oil Supplementation on Cardiovascular Function in Postmenopausal Women.

M

Marymount University

Status

Completed

Conditions

Hypertension
Elevated Blood Pressure

Treatments

Other: Pumpkin Seed Oil
Other: Placebo

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Postmenopausal women have a higher prevalence of cardiovascular (CV) disease than age-match men. Growing evidence from rat studies have demonstrated CV-protective effects of pumpkin seed oil (PSO).

The investigators hypothesis is that PSO would improve CV health in postmenopausal women.

Full description

The purpose of the study is to examine the effects of 6 weeks of PSO on arterial and autonomic function in postmenopausal women. Specific aims of the study are to:

To investigate the extent to which PSO will improve cardiovascular disease risk factors by assessing arterial stiffness, aortic BP and wave reflection, and autonomic function (heart rate variability).

Enrollment

23 patients

Sex

Female

Ages

45 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Female
  • 45 to 65 years of age
  • At least 1 year after menopause
  • BMI <39.9
  • Sedentary or low active (less than 2 hr per wk)

Exclusion criteria

  • known heart disease
  • peripheral vascular disease
  • diabetes, body mass index
  • BMI> 40 kg/m2
  • other chronic diseases
  • taking medications (e.g., hormone replacement therapy, beta blockers, calcium channel blockers, antidepressants and stimulants) that could affect the outcome variables
  • smokers
  • history of steady exercise or received exercise training and dietary changes in the last year

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

23 participants in 2 patient groups, including a placebo group

Pumpkin Seed Oil
Experimental group
Description:
This arm involved 6 weeks of PSO consumption. Subject were supplemented with 3 g/day of PSO which was ingested in the form of 1g capsules with each main meal of the day (breakfast, lunch and dinner). Likewise,
Treatment:
Other: Pumpkin Seed Oil
Placebo
Placebo Comparator group
Description:
This arm involved 6 weeks of placebo consumption. Subject consumed 1 capsule of maltodextrin with each main meal of the day to match the dose and number of capsules ingested daily by the PSO group.
Treatment:
Other: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems